Amedeo Smart

Free Medical Literature Service



Bladder Cancer

  Free Subscription

Articles published in
Cancer Res
    May 2018
  1. CHEN A, Fu G, Xu Z, Sun Y, et al
    Detection of Bladder Cancer Via Microfluidic Immunoassay and Single-Cell DNA Copy Number Alteration Analysis of Captured Urinary Exfoliated Tumor Cells.
    Cancer Res. 2018 May 22. pii: 0008-5472.CAN-17-2615.
    >> Share

    February 2018
  2. DAIZUMOTO K, Yoshimaru T, Matsushita Y, Fukawa T, et al
    A DDX31/mutant-p53/EGFR axis promotes multistep progression of muscle invasive bladder cancer.
    Cancer Res. 2018 Feb 13. pii: 0008-5472.CAN-17-2528.
    >> Share

    September 2017
  3. GOLDSTEIN JT, Berger AC, Shih J, Duke FF, et al
    Genomic activation of PPARG reveals a candidate therapeutic axis in bladder cancer.
    Cancer Res. 2017 Sep 18. pii: canres.1701.2017.
    >> Share

  4. DUEX JE, Owens C, Chauca-Diaz A, Dancik GM, et al
    Nuclear CD24 Drives Tumor Growth and Is Predictive of Poor Patient Prognosis.
    Cancer Res. 2017;77:4858-4867.
    >> Share

    April 2017
  5. VAN KAMPEN JGM, van Hooij O, Jansen CF, Smit FP, et al
    miRNA-520f Reverses Epithelial-to-Mesenchymal Transition by Targeting ADAM9 and TGFBR2.
    Cancer Res. 2017;77:2008-2017.
    >> Share

    March 2017
  6. NICHOLSON J, Jevons S, Groselj B, Ellermann S, et al
    E3 ligase cIAP2 mediates downregulation of MRE11 and radiosensitization in response to HDAC inhibition in bladder cancer.
    Cancer Res. 2017 Mar 31. pii: canres.3232.2016.
    >> Share

    February 2017
  7. MIAO L, Liu Q, Lin CM, Luo C, et al
    Targeting Tumor-Associated Fibroblasts for Therapeutic Delivery in Desmoplastic Tumors.
    Cancer Res. 2017;77:719-731.
    >> Share

    January 2017
  8. OWCZAREK TB, Kobayashi T, Ramirez R, Rong L, et al
    ARF confers a context-dependent response to chemotherapy in muscle invasive bladder cancer.
    Cancer Res. 2017 Jan 12. pii: canres.2621.2016.
    >> Share

    August 2016

  9. Correction: ATF3 Suppresses Metastasis of Bladder Cancer by Regulating Gelsolin-Mediated Remodeling of the Actin Cytoskeleton.
    Cancer Res. 2016;76:4592.
    >> Share

    March 2016
  10. WANG M, Li Z, Chu H, Lv Q, et al
    Genome-Wide Association Study of Bladder Cancer in a Chinese Cohort Reveals a New Susceptibility Locus at 5q12.3.
    Cancer Res. 2016.
    >> Share

    December 2015
  11. LI C, Du Y, Yang Z, He L, et al
    GALNT1-mediated glycosylation and activation of sonic hedgehog signaling maintains the self-renewal and tumor-initiating capacity of bladder cancer stem cells.
    Cancer Res. 2015 Dec 16. pii: canres.2309.2015.
    >> Share

    October 2015
  12. PALMBOS PL, Wang L, Yang H, Wang Y, et al
    ATDC/TRIM29 drives invasive bladder cancer formation through microRNA-mediated and epigenetic mechanisms.
    Cancer Res. 2015 Oct 15. pii: canres.0603.2015.
    >> Share

  13. REMY E, Rebouissou S, Chaouiya C, Zinovyev A, et al
    A Modeling Approach to Explain Mutually Exclusive and Co-Occurring Genetic Alterations in Bladder Tumorigenesis.
    Cancer Res. 2015;75:4042-52.
    >> Share

    May 2015
  14. HE F, Melamed J, Tang MS, Huang C, et al
    Oncogenic HRAS Activates Epithelial-to-Mesenchymal Transition and Confers Stemness to p53-Deficient Urothelial Cells to Drive Muscle Invasion of Basal Subtype Carcinomas.
    Cancer Res. 2015;75:2017-28.
    >> Share

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016